|
US3239345A
(en)
|
1965-02-15 |
1966-03-08 |
|
Estrogenic compounds and animal
growth promoters |
|
US4411890A
(en)
|
1981-04-14 |
1983-10-25 |
Beckman Instruments, Inc. |
Synthetic peptides having pituitary growth hormone releasing activity
|
|
US4036979A
(en)
|
1974-01-25 |
1977-07-19 |
American Cyanamid Company |
Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate
|
|
AU637316B2
(en)
|
1988-01-28 |
1993-05-27 |
Eastman Kodak Company |
Polypeptide compounds having growth hormone releasing activity
|
|
AU628322B2
(en)
|
1988-01-28 |
1992-09-17 |
Eastman Kodak Company |
Polypeptide compounds having growth hormone releasing activity
|
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
|
CA2092718C
(en)
|
1990-10-25 |
2007-08-07 |
Grace H. W. Wong |
Use of protective agents against reactive oxygen species
|
|
US5663146A
(en)
|
1991-08-22 |
1997-09-02 |
Administrators Of The Tulane Educational Fund |
Polypeptide analogues having growth hormone releasing activity
|
|
CA2147503A1
(en)
|
1992-11-06 |
1994-05-26 |
Judith M. Pisano |
Substituted dipeptide analogs promote release of growth hormone
|
|
US5726319A
(en)
|
1992-11-06 |
1998-03-10 |
Merck & Co., Inc. |
Biphenyl substituted dipeptide analogs promote release of growth hormone
|
|
WO1994013696A1
(en)
|
1992-12-11 |
1994-06-23 |
Merck & Co., Inc. |
Spiro piperidines and homologs which promote release of growth hormone
|
|
US5578593A
(en)
|
1992-12-11 |
1996-11-26 |
Merck & Co., Inc. |
Spiro piperidines and homologs promote release of growth hormone
|
|
HUT75224A
(en)
|
1993-10-19 |
1997-04-28 |
Merck & Co Inc |
Combination of bisphosphonates and growth hormone secretagogues
|
|
US5494919A
(en)
|
1993-11-09 |
1996-02-27 |
Merck & Co., Inc. |
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
US5492916A
(en)
|
1993-12-23 |
1996-02-20 |
Merck & Co., Inc. |
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
KR960705808A
(ko)
|
1993-11-09 |
1996-11-08 |
조셉 에프. 디프리마 |
성장 호르몬의 방출을 촉진시키는 피페리딘, 피롤리딘 및 헥사하이드로-1H-아제핀(Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone)
|
|
WO1995014666A1
(en)
|
1993-11-24 |
1995-06-01 |
Merck & Co., Inc. |
Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
|
|
US5721251A
(en)
|
1993-12-10 |
1998-02-24 |
Merck & Co., Inc. |
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
|
|
AU683121B2
(en)
|
1993-12-23 |
1997-10-30 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US5721250A
(en)
|
1993-12-23 |
1998-02-24 |
Merck & Co. Inc. |
Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
|
WO1995017423A1
(en)
|
1993-12-23 |
1995-06-29 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US5777112A
(en)
|
1994-06-13 |
1998-07-07 |
Merck & Co., Inc |
Piperazine compounds promote release of growth hormone
|
|
AU3128195A
(en)
|
1994-07-20 |
1996-02-16 |
Merck & Co., Inc. |
Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone
|
|
US5798337A
(en)
|
1994-11-16 |
1998-08-25 |
Genentech, Inc. |
Low molecular weight peptidomimetic growth hormone secretagogues
|
|
AU4495996A
(en)
|
1995-01-25 |
1996-08-14 |
Nippon Chemiphar Co. Ltd. |
Dihydrophenazine derivatives
|
|
ID18218A
(id)
|
1995-01-27 |
1998-03-19 |
Novo Nordisk As |
Senyawa dengan sifat-sifat pelepas hormon pertumbuhan
|
|
AU4534696A
(en)
|
1995-02-09 |
1996-08-27 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
WO1996024580A1
(en)
|
1995-02-09 |
1996-08-15 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US5559128A
(en)
|
1995-04-18 |
1996-09-24 |
Merck & Co., Inc. |
3-substituted piperidines promote release of growth hormone
|
|
AU5486396A
(en)
|
1995-04-19 |
1996-11-07 |
Merck & Co., Inc. |
Process for the preparation of spiroindolines
|
|
WO1996035713A1
(en)
|
1995-05-08 |
1996-11-14 |
Pfizer, Inc. |
Dipeptides which promote release of growth hormone
|
|
FI974368A7
(fi)
|
1995-05-29 |
1997-11-28 |
Pfizer |
Kasvuhormonin vapautumista edistäviä dipeptidejä
|
|
AU711104B2
(en)
|
1995-06-22 |
1999-10-07 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
EP0761219A1
(en)
|
1995-08-21 |
1997-03-12 |
Eli Lilly And Company |
2-Acylaminopropanamines as growth hormone secretagogues
|
|
WO1997006803A1
(en)
|
1995-08-21 |
1997-02-27 |
Eli Lilly And Company |
2-acylaminopropanamides as growth hormone secretagogues
|
|
EP0766966A3
(en)
|
1995-09-08 |
2001-02-28 |
Eli Lilly And Company |
Method of treating insulin resistance
|
|
AU7169696A
(en)
|
1995-09-26 |
1997-04-17 |
Merck & Co., Inc. |
3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone
|
|
EA199800337A1
(ru)
|
1995-10-27 |
1998-10-29 |
Мерк Энд Ко., Инк. |
Способ получения гормона роста, усиливающего секрецию
|
|
US5767124A
(en)
|
1995-10-27 |
1998-06-16 |
Merck & Co., Inc. |
Polymorphic forms of a growth hormone secretagogue
|
|
PL326428A1
(en)
|
1995-10-27 |
1998-09-14 |
Merck & Co Inc |
Method of obtaining a compound stimulating hormonal secretion of a growth hormone
|
|
AU7522896A
(en)
|
1995-10-27 |
1997-05-15 |
Merck & Co., Inc. |
Wet granulation formulation of a growth hormone secretagogue
|
|
ES2268713T3
(es)
|
1995-12-13 |
2007-03-16 |
MERCK & CO., INC. |
Ensayos de receptores de secretagogos de la hormona de crecimiento.
|
|
JP3754084B2
(ja)
|
1995-12-13 |
2006-03-08 |
メルク エンド カンパニー インコーポレーテッド |
成長ホルモン分泌促進薬受容体ファミリー
|
|
IT1277113B1
(it)
|
1995-12-20 |
1997-11-04 |
Romano Deghenghi |
Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
|
|
WO1997022367A1
(en)
|
1995-12-20 |
1997-06-26 |
Merck & Co., Inc. |
Radiolabeled growth hormone secretagogue
|
|
CZ195098A3
(cs)
*
|
1995-12-22 |
1998-10-14 |
Novo Nordisk A/S |
Sloučeniny uvolňující růstový hormon
|
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
|
WO1997034604A1
(en)
|
1996-03-21 |
1997-09-25 |
Merck & Co., Inc. |
4-spiroindoline piperidines promote release of growth hormone
|
|
WO1997036873A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
|
SE9601397D0
(sv)
|
1996-04-12 |
1996-04-12 |
Pharmacia Ab |
Use of growth hormone
|
|
JP2000510453A
(ja)
|
1996-04-19 |
2000-08-15 |
ノボ ノルディスク アクティーゼルスカブ |
成長ホルモン遊離特性を有する化合物
|
|
US5919777A
(en)
|
1996-04-24 |
1999-07-06 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
KR20000010626A
(ko)
|
1996-04-24 |
2000-02-25 |
한센 핀 베네드, 안네 제헤르 |
성장호르몬 방출성을 갖는 화합물
|
|
WO1997041878A1
(en)
|
1996-05-07 |
1997-11-13 |
Merck & Co., Inc. |
Treatment of mood disorders with a growth hormone secretagogue
|
|
EP0900086A4
(en)
|
1996-05-07 |
2000-01-12 |
Merck & Co Inc |
IMPROVING THE SLEEP BY MEANS OF A SUBSTANCE PROMOTING THE SECRETION OF GROWTH HORMONES
|
|
WO1997043278A1
(en)
|
1996-05-14 |
1997-11-20 |
Novo Nordisk A/S |
Somatostatin agonists and antagonists
|
|
WO1997044042A1
(en)
|
1996-05-22 |
1997-11-27 |
Arch Development Corporation |
Sleep quality improvement using a growth hormone secretagogue
|
|
PL330239A1
(en)
|
1996-05-31 |
1999-05-10 |
Novo Nordisk As |
Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment
|
|
US5922770A
(en)
|
1996-07-22 |
1999-07-13 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
WO1998010653A1
(en)
|
1996-09-13 |
1998-03-19 |
Merck & Co., Inc. |
Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
|
|
AU4993497A
(en)
|
1996-10-25 |
1998-05-22 |
Merck & Co., Inc. |
Convergent process for the preparation of a growth hormone secretagogue
|
|
SE9703929D0
(sv)
|
1996-11-22 |
1997-10-28 |
Pharmacia & Upjohn Ab |
Therapeutical use and method
|
|
AU6747498A
(en)
|
1997-04-11 |
1998-11-11 |
Sumitomo Pharmaceuticals Company, Limited |
Benzene derivatives
|
|
JP2000514838A
(ja)
|
1997-05-14 |
2000-11-07 |
藤沢薬品工業株式会社 |
成長ホルモンの放出を促進するピペリジノ誘導体
|
|
US5861149A
(en)
|
1997-06-04 |
1999-01-19 |
Polyheal Ltd. |
Methods for wound treatment
|
|
EP1005484A1
(en)
|
1997-06-20 |
2000-06-07 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
UA64751C2
(uk)
|
1997-06-25 |
2004-03-15 |
Пфайзер Продактс Інк. |
Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
|
|
WO1998058947A1
(en)
|
1997-06-25 |
1998-12-30 |
Pfizer Inc. |
Dipeptide derivatives as growth hormone secretagogues
|
|
UA53716C2
(uk)
|
1997-06-25 |
2003-02-17 |
Пфайзер Продактс Інк. |
Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
|
|
ZA987383B
(en)
|
1997-08-19 |
2000-02-17 |
Lilly Co Eli |
Treatment of congestive heart failure with growth hormone secretagogues.
|
|
US6864250B1
(en)
|
1997-08-22 |
2005-03-08 |
Kaken Pharmaceutical Co., Ltd. |
N-acylated lipophilic amino acid derivatives
|
|
HUP0100777A3
(en)
|
1998-01-16 |
2001-12-28 |
Novo Nordisk As |
Tripeptides with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use
|
|
WO1999039730A1
(en)
|
1998-02-09 |
1999-08-12 |
Kaken Pharmaceutical Co., Ltd. |
Oral preparations containing peptides promoting the secretion of growth hormone
|
|
JP2002505340A
(ja)
|
1998-03-03 |
2002-02-19 |
ノボ ノルディスク アクティーゼルスカブ |
(2e)−5−アミノ−5−メチルヘキセ−2−エン酸n−メチル−n−((1r)−1−(n−メチル−n−((1r)−1−(メチルカルバモイル)−2−フェニルエチル)カルバモイル)−2−(2−ナフチル)エチル)アミドの新規な塩
|
|
JP4142253B2
(ja)
|
1998-05-11 |
2008-09-03 |
ノボ ノルディスク アクティーゼルスカブ |
成長ホルモン放出特性を有する化合物
|
|
JP4574849B2
(ja)
|
1998-06-09 |
2010-11-04 |
サファイア セラピューティクス,インコーポレイティド |
成長ホルモン放出特性を有する化合物を調製するための方法
|
|
CA2335112A1
(en)
|
1998-06-16 |
1999-12-23 |
Hua Zhu Ke |
Therapeutic combinations for musculoskeletal frailty
|
|
ZA993975B
(en)
|
1998-06-16 |
2000-12-15 |
Pfizer Prod Inc |
Combination therapy for musculoskeletal frailty.
|
|
DK1100824T3
(da)
|
1998-06-30 |
2011-06-20 |
Helsinn Therapeutics Us Inc |
Forbindelser med væksthormonfrigivende egenskaber
|
|
CA2340701C
(en)
|
1998-08-20 |
2009-05-26 |
Sumitomo Pharmaceuticals Co., Ltd. |
Oxindole derivatives as growth hormone releasers
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
CA2395996A1
(en)
|
1999-12-28 |
2001-07-05 |
Kaken Pharmaceutical Co., Ltd. |
Neuroprotective drug
|
|
US6967237B2
(en)
|
2000-05-30 |
2005-11-22 |
Merck & Co., Inc. |
Ghrelin analogs
|
|
DE60140285D1
(de)
|
2000-05-31 |
2009-12-10 |
Pfizer Prod Inc |
Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts
|
|
ATE370119T1
(de)
|
2000-06-13 |
2007-09-15 |
Zentaris Gmbh |
Wachstumhormonsekretionsförderer
|
|
AU2001274601A1
(en)
|
2000-06-23 |
2002-01-02 |
Kaken Pharmaceutical Co., Ltd. |
Preventives or remedies for heart failure
|
|
ITMI20011445A1
(it)
|
2001-07-06 |
2003-01-06 |
Europ Geie |
Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita
|
|
CU23043A1
(es)
|
2001-12-20 |
2005-05-20 |
Ct Ingenieria Genetica Biotech |
Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
|
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
WO2005039625A1
(en)
|
2003-10-28 |
2005-05-06 |
Rheoscience A/S |
Growth hormone secretagogue receptor agonists
|
|
US7504506B2
(en)
|
2003-11-04 |
2009-03-17 |
Elixir Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
WO2005048916A2
(en)
|
2003-11-20 |
2005-06-02 |
Biovitrum Ab |
Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders
|